1奥多母(Richard B．O)主编.安德鲁斯皮肤病学[A]..英文影印版/原名《Andrew s disesse of the skin》第9版[C].北京:科学出版社,2001.157—160.
2Brunsting LA,Goeckerman WH,O'Leary PA.Pyoderma gangrenosum:clinical and experimental observation in five case occurring in adults.Arch Dermatol,1930,22:665.
3Lebbe C, Moulonguet-Michan I, Perrin P, et al. Steroid-respansive pyoderma gangrenosum with vulvar and pulmonary involvement. J Am Acad Dermatol,1992,27:623-625.
4Vignon-Pennamen MD, Zelinsky-Gurung A, Janssen F, et al. Pyoderma gangrenosum with pulmonary involvement. Arch Dermatol, 1989,125:1239-1242.
5Mlika RB, Riahi I, Fenniche S,et al. Pyoderma gangrenosum: report of 21 cases, hat J Dermaol,2002,41:65-68.
6Wollina U. Clinical management of pyoderma gangrenosum. Am J Clin Dermatol,2002,3:149-158.
7Wines N,Wines M, Ryman W. Understanding pyoderma gangrenosum: a review. Med Gen Med,2001,3:6.
8Lyon CC,Stapleton M,Smith AJ,et el.Topical tacrolimus in the mangement of peristomal pyoderma gangrenosum.J Dermatolog Treat,2001,12:13-17.
9Hagman JG,Carrozzo AM,Campione E,et al.The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum.J Dermatolog Treat,2001,12:19-22.
10Tan MH, Gordon M,Lebwohl O, et al. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol,2001,137:930-933.
